tiprankstipranks
Akoya Biosciences (AKYA)
NASDAQ:AKYA
US Market

Akoya Biosciences (AKYA) Income Statement

Compare
140 Followers

Akoya Biosciences Income Statement

Last quarter (Q3 2024), Akoya Biosciences's total revenue was $18.81M, a decrease of -25.39% from the same quarter last year. In Q3, Akoya Biosciences's net income was $-10.53M. See Akoya Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 96.63M$ 74.86M$ 54.92M$ 42.44M$ 42.24M
Gross Profit
$ 56.30M$ 43.39M$ 34.22M$ 25.91M$ 24.66M
Operating Expenses
$ 113.97M$ 109.60M$ 71.44M$ 37.40M$ 38.17M
Depreciation and Amortization
$ 8.89M$ 7.15M$ 4.79M$ 3.81M$ 3.06M
EBITDA
$ -45.63M$ -58.81M$ -35.17M$ -10.13M$ -9.62M
Operating Income
$ -57.67M$ -66.21M$ -37.23M$ -11.49M$ -13.50M
Other Income/Expenses
$ -5.62M$ -4.41M$ -3.78M$ -4.65M$ -2.25M
Pretax Income
$ -63.28M$ -70.52M$ -43.08M$ -16.66M$ -14.56M
Net Income
$ -63.32M$ -70.64M$ -42.94M$ -16.71M$ -14.75M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.43$ -1.87$ -1.15$ -0.45$ -0.40
Diluted EPS
$ -1.43$ -1.87$ -1.15$ -0.45$ -0.40
Weighted Average Shares Outstanding
44.43M 37.75M 37.42M 37.11M 37.11M
Weighted Average Shares Outstanding (Diluted)
44.43M 37.75M 37.42M 37.11M 37.11M
Currency in USD

Akoya Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis